How Does Charles River Associates Company Work?

Reputational capital, a deep bench of credentialed experts, cross-practice collaboration, and data/technology partnerships drive high win rates and premium pricing on complex mandates.

• Proprietary models: demand and price elasticity, merger simulations, cost-of-capital, HEOR, energy dispatch and capacity expansion
• Licensed datasets: claims, IQVIA, regional ISO energy data supporting modeling and HEOR
• Academic affiliations and former regulators frequently serve as testifying experts
• Direct enterprise sales led by senior partners, supplemented by law-firm referrals and long-cycle relationships

Litigation drives the largest share while regional exposure concentrates in North America.

• Practice mix (2024 approximate): Litigation & Regulatory Economics 55–60%, Strategy & Management Consulting 35–40%, Other 3–5%.
• Regional split: North America 70–75%, EMEA 20–25%, Rest of World ~5%.
• Typical utilization in core practices: mid-70s to low-80s percent; realization rates remain high for mission-critical matters.
• Representative hourly bands: experts $900–$1,500/hr, principals $500–$900/hr, consultants $250–$500/hr.

Competitive advantage relies on court‑tested methodologies, strong brand equity with top law firms and regulators, extensive expert networks, and deep sectoral teams offering integrated litigation and advisory work.

• Court‑tested economic and econometric methods used in high‑stakes litigation and regulatory matters.
• Multi‑decade expert network and relationships with leading law firms and antitrust authorities.
• Ongoing investment in generative AI‑assisted document review and econometric accelerators to improve throughput and margins while preserving evidentiary standards.
• Sector depth enabling bundled offerings: antitrust, valuation, HEOR, energy modeling and expert witness services.

Principal risk vectors include deal-cycle exposure, shifting enforcement, talent market tightness, and evidentiary standards; CRA mitigates some threats via expert differentiation and selective hires.

• Cyclicality: M&A-related antitrust work falls if global deal volume declines; US deal value fell by ~8% in 2024 versus 2023, increasing sensitivity to transaction flow.
• Regulatory pendulum: Changes in DOJ/FTC or EU Commission enforcement priorities can reroute demand for competition economics.
• Talent & cost: Tight hiring markets push compensation and utilization targets; lateral hiring is costly but necessary for specialty growth.
• AI & data risks: Automation can commoditize entry-level analytics; differentiation requires senior-led methodologies and proprietary models.
• Operational: FX exposure in EMEA and matter timing volatility create quarterly revenue and utilization swings.
• Evidentiary: Evolving Daubert/ admissibility standards and data privacy constraints raise litigation risk and project complexity.

If enforcement remains elevated in the US/EU and life sciences capital deployment accelerates, CRA can sustain premium pricing and expand profitability via high-rate expert engagements.

• Regulatory intensity: Sustained antitrust enforcement supports demand for economic testimony and complex modeling.
• Life sciences funding: Increased M&A and pipeline transactions drive HEOR and valuation mandates.
• Energy transition spend: Policy and capital flows into grid, hydrogen, and CCS create advisory opportunities.
• AI adoption: Productivity gains from AI can raise effective utilization if paired with senior oversight to avoid commoditization.